Introduction to Semax
In the field of neurobiology, Semax has emerged as a peptide of significant interest. It is a synthetic heptapeptide derived from a fragment of the adrenocorticotropic hormone (ACTH), specifically ACTH(4-10). Unlike its parent hormone, Semax exerts zero hormonal activity, making it a pure focus for neurological research.
Modulation of BDNF and NGF
The primary mechanism of action observed in laboratory environments is Semax’s profound ability to upregulate Brain-Derived Neurotrophic Factor (BDNF) and Nerve Growth Factor (NGF). These neurotrophins are critical for the survival, development, and function of neurons. By increasing the expression of these factors, Semax accelerates neurogenesis and synaptogenesis in vitro.
Neuroprotection in Hypoxic Models
Extensive cellular research has demonstrated Semax’s neuroprotective properties. When neuronal cells are exposed to hypoxic (low oxygen) conditions or oxidative stress, the introduction of Semax has been shown to stabilize cellular membranes and reduce the rate of apoptosis (programmed cell death). This positions it as an invaluable tool for researchers studying stroke models and neurodegenerative pathways.
Conclusion
As a highly stable and non-hormonal peptide, Semax remains a focal point in contemporary neurological research aimed at understanding cognitive preservation and synaptic plasticity.
Disclaimer: Semax is provided by Reta Peptide Lab strictly for in vitro laboratory evaluation.